The three CCP-related gene signatures–HSD11B1, NDRG1 and CDCA3–may each independently predict the clinical outcomes of cutaneous melanoma patients, according to our prognostic study (both in OS and DSS). Here, NDRG1 is linked to cutaneous melanoma.